Equillium Results Presentation Deck

Change in UPCR over time 6- imm 12 10 11 2- 1 1410 2 6 10 12 neg ក-ហ៊ូ. 045 nes nes n43 28 143 32 143 36 Baseline Number of Subjects Median Mean (SD) Week 12 Number of Subjects Median Mean (SD) Week 28/EOS^ Number of Subjects Median Mean (SD) Change in UPCR from Baseline n/a n/a n/a equillium eGFR estimated EOS error: 10 -51.3% -36.7% (49.3%) 6 -59.1% -57.7% (28.0%) Daily Steroid Dose (prednisone equivalents) 10 50.0 mg 46.0 (12.6) mg 9 6.2 mg 10.5 (10.7) mg 16 18 Study Week Arithmetic mean UPCR noted with SE: Figure includes data available at each time point AEOS includes subjects that completed follow up visits: # Steroids recorded at Week 24: Based on interim data from 2 Sep 2022-subject to change: UPCR correlation with ACR r=0.99; eGFRs remained stable during treatment period. 5 5.0 mg" 7.5 (5.7) mg# 29

View entire presentation